Literature DB >> 15138845

Endoscope-assisted microsurgery for tumors of the septum pellucidum: surgical considerations and benefits of the method in the treatment of four serial cases.

M Fratzoglou1, A R Leite dos Santos, I Gawish, A Perneczky.   

Abstract

Neoplasms that primarily originate from the septum pellucidum are extremely rare. Generally the septum pellucidum is involved in direct extension of tumors that arise from the neighboring structures, principally the corpus callosum. Endoscope-assisted techniques form a useful adjunct to common microsurgical procedures to completely remove intraventricular lesions. There are two main advantages of endoscope-assisted surgery over common microsurgical techniques: reduction of superficial brain retraction with less iatrogenic trauma to the neighboring structures and inspection of hidden corners depict simultaneously anatomical details which are not precisely visible in the zoomed and thus light-reduced beam of the microscope. Four patients with septum pellucidum tumors underwent surgery by a transcallosal approach. In all four patients the endoscope-assisted microsurgery technique was used to remove the tumor. In one of the four patients neuronavigation was additionally used for guidance. Complete tumor excision was achieved in all patients. The histological findings showed pilocytic astrocytoma in two cases, one subependymoma and one neurocytoma, respectively. There were no postoperative complications. Endoscope-assisted microsurgery provides maximum efficiency to remove the septum pellucidum tumors with minimum invasiveness.

Entities:  

Mesh:

Year:  2004        PMID: 15138845     DOI: 10.1007/s10143-004-0332-y

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  32 in total

1.  Stereotactic biopsies guided by an optical navigation system: technique and clinical experience.

Authors:  P Grunert; J Espinosa; C Busert; M Günthner; R Filippi; S Farag; N Hopf
Journal:  Minim Invasive Neurosurg       Date:  2002-03

Review 2.  The septum pellucidum: normal and abnormal.

Authors:  M Sarwar
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

3.  Choriocarcinoma of the septum pellucidum: case report.

Authors:  S Koyama; T Tsubokawa; Y Katayama; H Hirota
Journal:  Surg Neurol       Date:  1991-06

4.  Limited exposure in cerebral surgery. Technical note.

Authors:  D H Wilson
Journal:  J Neurosurg       Date:  1971-01       Impact factor: 5.115

5.  Cava septi pellucidi et vergae: their normal and pathogical states.

Authors:  C M Shaw; E C Alvord
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

6.  Neurosurgical endoscopy using the side-viewing telescope.

Authors:  M L Apuzzo; M D Heifetz; M H Weiss; T Kurze
Journal:  J Neurosurg       Date:  1977-03       Impact factor: 5.115

7.  [Fornix and septal tumor (author's transl)].

Authors:  E Laine; S Blond
Journal:  Neurochirurgie       Date:  1980       Impact factor: 1.553

8.  Endoscopic biopsy of intraventricular tumors with the use of a ventriculofiberscope.

Authors:  T Fukushima
Journal:  Neurosurgery       Date:  1978 Mar-Apr       Impact factor: 4.654

9.  Endoscopic management of craniopharyngiomas: a review of 3 cases.

Authors:  J Abdullah; J Caemaert
Journal:  Minim Invasive Neurosurg       Date:  1995-06

Review 10.  Subependymoma of the septum pellucidum radiologically indistinguishable from cavernous angioma--case report.

Authors:  T Yamasaki; H Kikuchi; J Yamashita; Y Goto; H Yamabe
Journal:  Neurol Med Chir (Tokyo)       Date:  1989-11       Impact factor: 1.742

View more
  2 in total

1.  Optimal invasive key-hole neurosurgery with a miniaturized 3D chip on the tip: Microendoscopic device.

Authors:  Patra Charalampaki; Alhadi Igressa; Mehran Mahvash; Ioannis Pechlivanis; Bernhard Schick
Journal:  Asian J Neurosurg       Date:  2013-07

2.  Corpus Callosum Swelling after Resection of Intraventricular Central Neurocytoma.

Authors:  Daiki Aburakawa; Masayuki Kanamori; Toshiaki Akashi; Shiho Sato; Ryuta Saito; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.